# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Satoyoshi Syndrome
- **MONDO ID:**  (if available)
- **Category:** Autoimmune

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Satoyoshi Syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-23T16:55:56.336159

1. matsuura2007satoyoshisyndromehas pages 1-2
2. saima2023impendingcentralretinal pages 4-5
3. pozo2020gastrointestinalmanifestationsin pages 1-2
4. matsuura2007satoyoshisyndromehas pages 2-4
5. montanaro2022autoimmunityinsatoyoshi pages 5-8
6. montanaro2022autoimmunityinsatoyoshi pages 1-5
7. saima2023impendingcentralretinal pages 1-2
8. pozo2019treatmentofsatoyoshi pages 1-2
9. saima2023impendingcentralretinal pages 2-4
10. montanaro2022autoimmunityinsatoyoshi pages 8-11
11. pozo2019treatmentofsatoyoshi pages 2-4
12. pozo2020gastrointestinalmanifestationsin pages 2-4
13. https://doi.org/10.1002/mus.20773
14. https://doi.org/10.1186/s13023-019-1120-7
15. https://doi.org/10.1186/s13023-020-01395-8
16. https://doi.org/10.1101/2022.07.05.22277272
17. https://doi.org/10.1097/MD.0000000000033284
18. https://doi.org/10.1093/jcag/gwad061.178
19. https://doi.org/10.1186/s13023-019-1120-7,
20. https://doi.org/10.1186/s13023-020-01395-8,
21. https://doi.org/10.1101/2022.07.05.22277272,
22. https://doi.org/10.1002/mus.20773,
23. https://doi.org/10.1097/md.0000000000033284,
24. https://doi.org/10.1093/jcag/gwad061.178,